HPV status in head and neck tumors

Area of Science:

• Oncology
• Virology
• Pathology

Background:

• Human papillomavirus (HPV) infection is a known risk factor for head and neck squamous cell carcinoma (HNSCC).
• The prevalence and specific types of HPV in HNSCC, especially in Middle Germany, require further investigation.
• Understanding HPV's role is crucial for diagnosis and treatment strategies.

Purpose of the Study:

• To determine the prevalence of high-risk HPV (HR-HPV) in a cohort of HNSCCs from Middle Germany.
• To compare the efficacy of PCR-agarose gel electrophoresis and DNA microarray chip hybridization for HPV detection.
• To assess the correlation between tumor morphology and HPV status, and the concordance of HPV status between primary tumors and metastases.

Main Methods:

• Analysis of 76 HNSCC samples (from 52 patients, including 23 primary-metastasis pairs) using PCR-agarose gel electrophoresis and DNA microarray chip hybridization.
• Assessment of tumor morphology for predictive value regarding HPV association.
• Statistical analysis to compare detection methods and evaluate concordance.

Main Results:

• High-risk HPV was detected in 76% of patients and 81% of tumor samples, with tonsillar carcinomas showing the highest prevalence (even exceeding reported literature rates).
• DNA chip analysis identified significantly more HPV-positive cases than PCR-agarose gel electrophoresis.
• HPV 16 was the predominant type, and a high concordance (91%) was observed between primary tumors and their corresponding metastases regarding HPV status.

Conclusions:

• HR-HPV is highly prevalent in tonsillar carcinomas in Middle Germany, confirming its significant role in HNSCC etiology.
• DNA microarray chip hybridization is a more sensitive method for detecting HPV in HNSCC compared to traditional PCR-agarose gel electrophoresis.
• Tumor morphology can be an indicator, but molecular testing is essential for definitive HPV status confirmation in HNSCC.